Podcast 5 Apr 2024
Colossal Biosciences’ 2028 goal: Bringing back the woolly mammoth
Discover the pioneering work of Colossal Biosciences, a biotech firm leading the charge in de-extinction and endangered species preservation.
Synthetic biology
- Latest Posts
Best in Biotech 13 Feb 2024
Eight biotechs thriving in Seattle
In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large.
Best in Biotech 17 Oct 2023
Singapore’s biotech scene: six companies leading the way
Singapore set out to become a global biotech hub back in 2000, and, although still awaiting its big success story in the industry, it is currently a leading hub in the APAC region for R&D, biopharma manufacturing, and commercial operations, with a growing startup ecosystem that includes numerous biotech companies. In 2000, the government in […]
In Depth 7 Jul 2023
The future of food: what’s behind the cell-cultured meat industry regulations?
The first-ever lab-grown burger was created at Maastricht University in the Netherlands, and eaten at a news conference in London in 2013. While everyone who tried a bite had something different to say about the taste and texture of the meat, it was agreed that this could be the start of something big. The technology […]
News and Trends 4 Jul 2023
Camena Bioscience raises $10M for DNA synthesis platform
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its DNA synthesis platform, gSynth. Camena Bioscience is the first company to offer the enzyme-based DNA synthesis […]
News and Trends 10 May 2023
Scientists create first CRISPR-based drug candidate targeting the microbiome
A new CRISPR-based drug candidate targeting E. coli in the gut microbiome is in phase 1 clinical trials. According to a new paper published in Nature Biotechnology, it may improve the well-being of blood cancer patients and reduce their mortality rate from E. coli infections. Many people have experienced infections from E. coli, which are […]
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 28 Apr 2023
Six synthetic biology companies that have made a mark
The consequences of the climate crisis coupled with soil degradation and its impact on food and water security, seem dire. But, as ambitious as it may sound, synthetic biology companies could alleviate some of the environmental burden that the planet faces. As it involves the redesigning of organisms by genetically engineering them to have new, […]
News and Trends 7 Feb 2023
Evonetix closes $24M financing
Evonetix Ltd, a synthetic biology company bringing semiconductor technology to DNA synthesis, has completed a $24 million financing round, extending its total series B funding to over $54 million. This fundraise was led by existing investor Foresite Capital, with Molten Ventures, Morningside, DCVC, Cambridge Consultants, Civilization Ventures and Providence also participating in the round. The […]
In Depth 6 Feb 2023
The biggest private biotech investments in January 2023
The companies Asimov, BioRay Pharmaceuticals and Colossal Biosciences bagged the biggest biotech investments in January 2023. Around the world, synthetic biology players and firms developing treatments for hormonal disorders attracted the biggest funding rounds. 2023 began with a bang in terms of biotech funding, and there are signs of stabilization in biotech stocks after two […]
In Depth 20 Jan 2023
The future of single-cell microfluidics in cell engineering
By Richard Hammond, chief technical officer at Sphere Fluidics Single-cell microfluidic-based techniques continue to be a key enabling technology for cell engineering as they allow true single-cell level working, with the associated precision of measurement and control of environment, and a high level of automation, enabling the speed and scale necessary to process and search […]
News and Trends 20 Dec 2022
Ribbon Biolabs milestone to lead to 2023 market entry
DNA synthesis company Ribbon Biolabs has announced the successful implementation of its InfiniSynth platform for the automated assembly of sequence-agnostic and long DNA. The company achieved the milestone in collaboration with HighRes Biosolutions, a laboratory automation technology company. The InfiniSynth platform enables Ribbon Biolabs to enter the market in 2023 with a highly differentiated approach […]
Startup Scout 13 Dec 2022
Biomemory is making DNA hard drives cheap and sustainable
The world is running out of ways to store the mountains of data we produce. Biomemory is creating DNA-based hard drives that could store this information cheaply, sustainably and for centuries. Society has advanced very far in technologies to store critical data, moving from punched cards and floppy disks in the 20th century to hard […]
ADVERTISEMENT